This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dementia due to Parkinson's disease
PD_DEMENTIA
obsolete_dementia: ['An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
778 |
4. Check minimum number of eventsNone |
778 |
5. Include endpointsNone |
778 |
6. Filter based on genotype QC (FinnGen only) |
778 |
Control definitions (FinnGen only)
- Control exclude
- G6_PARKINSON
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Dementia due to Parkinson's disease
based on the number of shared cases.
Similar with more cases:
- Dementia due to Parkinsons disease, excluding more controls
- Dementia in other diseases classified elsewhere
- Any dementia, excluding more controls
- Any dementia
- Dementia
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 778 | 271 | 507 |
| Unadjusted period prevalence (%) | 0.18 | 0.09 | 0.22 |
| Median age at first event (years) | 76.78 | 77.88 | 76.19 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 664
- Matched controls
- 6641
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N04BD01
ATC
selegiline; oral
912.7
323.0
304
6
G20
ICD-10 Finland
Parkinson disease
4503599627370496.0
323.0
630
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2169.3
323.0
626
48
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
323.0
286
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
323.0
600
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
323.0
536
*
N87
ICPC
Parkinsonism
382.4
289.0
272
12
N06DA03
ATC
rivastigmine; oral, transdermal
31.2
248.6
351
230
N04BD02
ATC
rasagiline; oral
+∞
179.5
164
*
N04BC05
ATC
pramipexole; oral
19.1
179.1
298
271
N04BC04
ATC
ropinirole; oral
139.0
153.0
159
15
N05AH04
ATC
quetiapine; oral
12.2
147.3
309
442
193
Kela drug reimbursment
Rasagiline
+∞
145.3
134
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
131.8
122
*
N04BX02
ATC
entacapone; oral
1430.2
125.2
118
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
8.1
81.9
207
351
N03AE01
ATC
clonazepam; systemic
9.5
58.3
127
161
H02AA02
ATC
fludrocortisone; oral
35.3
49.6
64
20
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
35.3
49.6
64
20
N04BC09
ATC
rotigotine; transdermal
179.9
48.6
50
*
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
47.5
45
*
N04BB01
ATC
amantadine; oral
24.3
43.6
62
28
R53
ICD-10 Finland
Malaise and fatigue
3.5
43.0
259
1020
I95.1
ICD-10 Finland
Orthostatic hypotension
7.0
40.5
106
175
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
39.2
333
1649
N04BC06
ATC
cabergoline; oral (dopamine agonists)
137.9
37.1
39
*
R25.1
ICD-10 Finland
Tremor, unspecified
10.9
36.8
72
73
N04AA02
ATC
biperiden; systemic
20.1
35.9
54
29
AA1AD
NOMESCO Finland
CT of head and brain
2.9
34.1
284
1352
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
33.6
32
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
33.4
242
1049
N04BC02
ATC
pergolide; oral
+∞
32.6
31
*
A06AD11
ATC
lactulose; oral
2.9
29.6
220
956
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
29.0
304
1621
G02CB01
ATC
bromocriptine; systemic
46.0
29.0
35
8
G04BD12
ATC
mirabegron; oral
3.6
28.4
143
467
F0232, G20
ICD-10 Finland
NA
+∞
27.3
26
*
F0230, G20
ICD-10 Finland
NA
+∞
27.3
26
*
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
+∞
25.2
24
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.4
25.0
98
254
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.6
23.8
72
141
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
43.3
23.8
29
7
S72.0
ICD-10 Finland
Fracture of neck of femur
4.4
22.8
87
219
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.2
22.3
55
82
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
15.8
22.2
36
24
S01.0
ICD-10 Finland
Open wound of scalp
3.7
21.5
102
313
SPAT1229
SPAT
Assessment of need for aid
3.3
21.0
115
393
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
20.7
247
1344
D21
ICPC
Swallowing problem
10.6
20.1
39
39
N05BA04
ATC
oxazepam; oral
2.4
20.0
205
1030
N29
ICPC
Neurological sympt/complt other
8.1
19.9
45
59
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
19.7
185
887
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
108.3
19.7
21
*
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
19.5
45
61
N06AX11
ATC
mirtazapine; oral
2.3
19.4
236
1290
N06AB10
ATC
escitalopram; oral
3.0
19.2
125
482
SPAT1216
SPAT
Assessment of functional ability
2.5
19.2
188
919
A28
ICPC
Limited function/disability NOS
2.4
19.1
207
1065
N19
ICPC
Speech disorder
12.3
19.0
34
29
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
18.8
18
*
SPAT1234
SPAT
Support of social functional capacity
3.7
18.7
87
261
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.2
18.6
104
361
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.6
18.1
54
104
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.5
17.9
89
282
W19
ICD-10 Finland
Unspecified fall
3.2
17.6
102
361
XF606
NOMESCO Finland
Ortostatic test
12.5
17.0
30
25
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
16.9
155
725
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
16.6
171
850
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.9
16.5
46
82
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
16.5
151
708
R1250
NOMESCO Finland
Evaluation of functional capability
8.7
16.4
35
42
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
15.7
15
*
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
15.7
15
*
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
4.6
15.5
54
124
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.9
15.4
65
180
Z2445
NOMESCO Finland
Psychologist
8.4
15.2
33
41
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
58.0
14.8
17
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
18.9
14.8
22
12
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
14.6
14
*
Z75.5
ICD-10 Finland
Holiday relief care
8.4
13.9
30
37
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
13.9
66
202
SPAT1167
SPAT
Insertion of urinary catheter
3.8
13.6
58
162
F0234, G20
ICD-10 Finland
NA
+∞
13.6
13
*
F023, G20
ICD-10 Finland
NA
+∞
13.6
13
*
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
26.4
13.4
18
7
N99
ICPC
Neurological disease other
10.8
13.3
25
24
SPAT1172
SPAT
Guidance concerning hydration
4.3
13.2
49
121
N05AX08
ATC
risperidone; systemic
2.8
13.1
91
361
N06AB04
ATC
citalopram; systemic
2.2
13.1
159
843
L28
ICPC
Limited function/disability (L)
2.1
12.4
170
945
C07AA05
ATC
propranolol; systemic
2.4
12.4
114
527
S06.0
ICD-10 Finland
Concussion
2.6
11.9
90
374
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
47.6
11.9
14
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.9
11.7
26
34
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
11.7
74
1474
U04
ICPC
Incontinence urine
3.4
11.7
56
173
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.7
11.7
29
45
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
66.1
11.6
13
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
11.5
144
769
G04BD09
ATC
trospium; oral
4.6
11.4
39
89
R4130
NOMESCO Finland
Speech therapy
5.1
11.3
35
72
R35
ICD-10 Finland
Polyuria
2.8
11.0
72
275
R41.0
ICD-10 Finland
Disorientation, unspecified
3.6
10.6
47
137
N05AH02
ATC
clozapine; systemic
14.5
10.5
17
12
R55
ICD-10 Finland
Syncope and collapse
2.2
10.4
117
593
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
10.4
75
305
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.8
10.3
67
254
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.9
10.0
40
107
N05AH03
ATC
olanzapine; systemic
4.1
9.9
38
98
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.4
9.8
86
388
S70.0
ICD-10 Finland
Contusion of hip
3.3
9.7
49
158
N30.0
ICD-10 Finland
Acute cystitis
2.2
9.7
110
560
N05BA06
ATC
lorazepam; systemic, sublingual
3.0
9.5
55
196
WYA20
NOMESCO Finland
Home visit
4.4
9.4
33
78
N04BX01
ATC
tolcapone; oral
+∞
9.4
9
*
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
4.3
9.4
34
83
A04
ICPC
Weakness/tiredness general
2.1
9.1
114
606
N28
ICPC
Limited function/disability (N)
5.4
9.0
26
50
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.9
9.0
36
97
G04BD11
ATC
fesoterodine; oral
3.6
8.8
39
114
SPAT1254
SPAT
Administration of medicine
1.9
8.6
137
794
F06.0
ICD-10 Finland
Organic hallucinosis
27.9
8.5
11
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
8.4
95
483
N04BC01
ATC
bromocriptine; oral
+∞
8.3
8
*
N06DA02
ATC
donepezil; oral
2.2
8.1
82
397
NF1AA
NOMESCO Finland
Hip X-ray examination
2.2
8.1
84
411
E86
ICD-10 Finland
Volume depletion
3.3
7.9
38
120
Z50.5
ICD-10 Finland
Speech therapy
8.2
7.6
16
20
R44.1
ICD-10 Finland
Visual hallucinations
10.2
7.6
14
14
R32
ICD-10 Finland
Unspecified urinary incontinence
3.7
7.4
30
83
N30.9
ICD-10 Finland
Cystitis, unspecified
2.6
7.3
50
198
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.6
7.3
31
89
K59.0
ICD-10 Finland
Constipation
2.4
7.3
59
255
Y94.0
ICD-10 Finland
Accident at home
4.7
7.3
23
50
N06AX16
ATC
venlafaxine; oral
2.4
7.2
59
259
N86
ICPC
Multiple sclerosis
20.3
7.1
10
5
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
20.3
7.1
10
5
R13
ICD-10 Finland
Dysphagia
2.4
7.1
59
260
S01
ICD-10 Finland
Open wound of head
5.4
7.1
20
38
F05.9
ICD-10 Finland
Delirium, unspecified
3.5
7.1
31
91
130
Kela drug reimbursment
Malignant tumour
0.3
7.0
12
425
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
6.8
57
252
UKC02
NOMESCO Finland
Cystoscopy
1.7
6.6
156
1020
P20
ICPC
Memory disturbance
1.7
6.6
136
857
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.5
165
1100
SPAT1053
SPAT
Memory test
1.7
6.5
169
1135
N06AX21
ATC
duloxetine; oral
2.3
6.5
57
258
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
6.5
131
820
I95.9
ICD-10 Finland
Hypotension, unspecified
4.1
6.4
23
57
N04AA01
ATC
trihexyphenidyl; oral
70.5
6.4
7
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
6.4
81
433
R47.1
ICD-10 Finland
Dysarthria and anarthria
5.3
6.4
18
35
SPAT1360
SPAT
Extensive global examination
2.1
6.3
66
325
N06AX03
ATC
mianserin; oral
2.9
6.3
36
128
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
6.3
36
128
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.2
537
4783
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
6.2
63
307
N06DX01
ATC
memantine; oral
1.9
6.2
87
483
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
6.0
98
570
F05.8
ICD-10 Finland
Other delirium
6.1
6.0
15
25
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
6.1
6.0
15
25
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
292
1700
2.15
22.05
2.1
1.8
nmol/l
1120.6
1183.5
0.51
192
1246
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
20
14
14.64
21.99
2.0
1.3
nmol/l
73.8
84.9
—
13
9
(3014271) Vancomycin [Susceptibility]
32
63
5.25
15.64
5.0
3.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
393
5034
0.56
14.19
3.6
4.7
mmol/l
1.4
1.4
0.20
321
4396
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
401
5100
0.56
13.99
3.5
4.8
mmol/l
4.2
4.3
0.81
329
4509
(3026008) Bacteria identified in Urine by Culture
333
2286
1.80
13.88
4.8
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
385
4882
0.58
12.26
3.2
4.2
mmol/l
1.1
1.2
3.86
305
4212
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
429
5272
0.58
11.84
4.0
5.4
mmol/l
2.4
2.4
0.54
346
4623
(3009508) Creatinine [Moles/volume] in Urine
107
1961
0.47
11.81
2.8
3.2
mmol/l
7.0
7.1
0.05
74
1574
(3012516) Albumin [Mass/volume] in Urine
109
1971
0.48
11.52
2.7
3.3
mg/l
732.8
360.8
0.23
63
1311
(3020682) Albumin/Creatinine [Ratio] in Urine
122
2102
0.50
11.08
3.8
4.0
mg/mmol
6.0
9.4
1.57
71
1373
(3023368) Bacteria identified in Blood by Culture
315
2239
1.68
10.87
4.1
4.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
289
2015
1.69
10.68
2.8
2.2
u/l
341.9
268.9
0.47
266
1867
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
1339
0.41
10.64
1.2
1.6
mmol/l
1.0
1.3
2.85
52
1085
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94
457
2.20
10.53
1.4
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
196
1331
1.63
7.59
2.0
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
500
4186
1.54
7.55
7.4
5.4
e6/l
6209.6
2626.8
0.29
14
88
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
435
5118
0.66
7.32
6.2
6.9
mmol/mol
40.9
41.8
1.03
360
4571
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
44
182
2.50
7.13
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
44
182
2.50
7.13
1.5
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
44
4.16
6.84
2.8
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
460
5278
0.69
6.00
4.4
5.2
mmol/l
6.1
6.2
1.67
357
4600
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
17
46
3.76
5.67
1.1
1.1
ng/l
35.3
39.8
0.21
12
25
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
363
2961
1.42
5.49
2.4
2.2
pmol/l
82.1
91.9
4.77
222
1541
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
437
5017
0.71
5.29
22.7
18.8
ml/min/173m2
77.8
68.1
19.26
362
4208
(3030467) Casts [#/volume] in Urine by Automated count
257
1987
1.44
5.14
3.7
3.5
e6/l
0.5
0.6
0.54
201
1569
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
140
2.42
5.13
1.4
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
112
1656
0.62
5.13
2.1
3.1
umol/l
10386.1
9682.1
0.03
80
1362
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
790
0.48
5.05
3.9
3.9
ug/l
3.2
31.6
1.97
33
673
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
413
0.30
4.89
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
315
2558
1.39
4.66
3.9
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
202
1524
1.44
4.53
4.1
3.1
mosm/kgh2o
610.3
561.8
2.85
171
1300
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
135
941
1.53
4.50
2.0
1.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
28
118
2.42
4.44
1.3
1.3
mg/l
502.7
549.9
0.32
23
111
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
461
0.38
4.38
1.1
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
134
938
1.52
4.37
2.0
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
212
1623
1.42
4.37
1.9
1.8
pmol/l
391.7
4415609.8
0.50
164
1291
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
37
706
0.50
4.22
1.2
1.2
iu/ml
84.0
40.1
0.32
12
226
(3002582) Erythrocytes [#/volume] in Urine
273
2193
1.38
4.22
4.0
3.6
e6/l
54.5
113.2
1.02
217
1755
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
52
286
1.88
4.22
2.1
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
238
1873
1.39
4.16
3.8
3.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
87
1304
0.63
4.14
3.9
3.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
93
2.52
3.99
1.3
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
664
0.50
3.93
1.3
1.2
u/ml
1.5
13.5
3.62
12
208
(3000492) Spirometry study
16
409
0.38
3.89
1.4
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
169
2196
0.71
3.88
2.2
2.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
232
1837
1.37
3.86
1.7
1.7
nmol/l
17.5
19.5
1.40
203
1540
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
282
2309
1.35
3.77
2.6
2.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
203
0.24
3.71
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
270
2215
1.34
3.52
6.4
4.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
30
574
0.50
3.47
1.2
1.3
titre
230.0
455.5
—
8
139
(3037467) Urinalysis macro (dipstick) panel - Urine
469
4166
1.32
3.43
6.3
4.8
—
—
—
0
0
(4010399)
17
396
0.42
3.36
1.2
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
382
0.41
3.36
1.1
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
17
392
0.42
3.28
1.2
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
109
777
1.47
3.25
6.0
4.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
314
1.70
3.15
2.2
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
290
2433
1.31
3.15
4.6
4.1
e6/l
119.3
141.9
0.23
222
1846
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
22
98
2.28
3.15
1.1
1.3
mmol/l
3.7
4.0
0.72
17
88
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
152
1161
1.38
3.10
3.3
3.4
e6/l
2.7
1.9
0.58
87
704
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
106
2.21
3.05
1.2
1.3
e6/l
1.7
83.5
0.87
16
86
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
23
106
2.21
3.05
1.5
1.4
e6/l
58.8
372.5
1.16
18
87
(3006653) Thiamine [Moles/volume] in Blood
10
29
3.48
3.05
1.1
1.0
nmol/l
141.4
131.7
—
10
29
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
156
1208
1.36
2.92
3.0
3.1
e6/l
1.1
1.1
0.03
91
744
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
130
1693
0.72
2.92
2.7
3.4
ug/l
0.7
0.8
0.57
87
1233
(3000494) Fungus identified in Specimen by Culture
41
673
0.59
2.84
1.2
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
599
0.56
2.83
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
110
807
1.42
2.83
10.2
10.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
329
2836
1.28
2.83
5.5
4.5
ng/l
45.7
58.5
0.50
271
2260
(3009261) Glucose [Presence] in Urine by Test strip
335
2897
1.27
2.80
5.8
4.5
estimate
0.0
0.0
0.00
78
551
(3035350) Ketones [Presence] in Urine by Test strip
333
2878
1.27
2.79
5.6
4.4
estimate
0.0
0.0
0.00
73
566
(3021601) Nitrite [Presence] in Urine by Test strip
329
2850
1.27
2.68
7.9
6.0
estimate
0.0
0.0
0.00
74
553
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
464
0.52
2.67
3.2
3.3
ml/min/173m2
72.6
54.8
0.93
12
203
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
236
1970
1.28
2.58
2.2
2.2
mg/l
2.8
3.2
2.96
169
1652
(3023410) Appearance of Cerebral spinal fluid
12
44
2.75
2.55
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
50
2.63
2.54
1.5
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
526
5654
0.78
2.52
8.6
11.4
u/l
16.7
23.8
10.16
455
5377
(3044889) 12 lead EKG panel
366
4093
0.80
2.46
4.4
4.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
51
2.58
2.45
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
53
789
0.65
2.44
1.2
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
64
0.00
2.43
0.0
1.2
—
9.3
—
0
47
(21494755) Public health laboratory ask at order entry panel
0
65
0.00
2.42
0.0
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
34
2.97
2.42
1.1
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
192
1576
1.29
2.37
3.3
2.7
e6/l
4.2
4.4
0.11
164
1392
(3006270) Folate [Moles/volume] in Blood
15
65
2.33
2.32
1.3
1.1
nmol/l
330.8
348.0
—
8
54
(3041096) Erythrocytes [Presence] in Urine by Automated
184
1507
1.29
2.31
6.2
4.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
386
3446
1.24
2.30
5.0
6.9
mmol/l
1.2
1.2
0.74
295
2848
(3017446) Testosterone [Moles/volume] in Serum or Plasma
23
413
0.54
2.24
1.6
2.2
nmol/l
13.6
11.6
0.55
17
344
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
62
0.00
2.23
0.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
42
2.64
2.19
1.3
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
55
0.00
2.07
0.0
2.4
—
77.2
—
0
11
(3029937) Albumin [Presence] in Urine by Test strip
197
1648
1.26
2.07
5.8
4.7
estimate
0.0
0.0
0.00
66
515
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
56
0.00
2.07
0.0
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
126
1.85
2.00
2.4
2.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
57
2.30
1.98
1.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
78
2.07
1.92
1.5
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
182
1.67
1.87
3.4
5.4
mmol/l
1.9
2.8
1.25
23
121
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
79
2.05
1.86
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
79
2.05
1.86
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
79
2.05
1.86
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
73
539
1.39
1.86
6.8
4.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
42
278
1.54
1.86
2.3
2.2
ug/l
491.9
660.4
0.27
36
262
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
40
2.52
1.84
1.1
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
417
3809
1.20
1.82
5.0
5.1
mmol/l
6.5
7.0
8.23
391
3586
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
247
0.48
1.81
1.1
1.3
—
—
—
0
0
(4035726)
34
520
0.64
1.81
1.1
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
80
2.02
1.81
1.5
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
35
2.59
1.80
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
35
2.59
1.80
1.4
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
25
146
1.74
1.79
1.7
2.6
umol/l
25.9
34.0
1.53
16
117
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
527
1.38
1.76
2.3
1.6
—
—
—
0
0
(4281824)
0
47
0.00
1.71
0.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
180
0.44
1.70
1.0
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
332
2986
1.20
1.67
3.3
4.9
g/l
33.3
34.0
1.29
282
2753
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
347
3138
1.19
1.64
4.7
6.1
mmol/l
1.2
1.2
0.55
297
2793
(1761482) Bacteria [#/volume] in Urine by Culture
37
246
1.53
1.63
8.6
5.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
77
1.97
1.60
1.5
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
209
2390
0.83
1.54
3.8
4.9
%
20.0
21.8
1.07
108
1299
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
44
2.29
1.53
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
142
0.42
1.53
1.5
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
43
0.00
1.52
0.0
1.4
—
—
—
0
0
(4094501)
5
128
0.39
1.50
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
153
1293
1.23
1.46
5.4
5.1
kg/l
1.0
1.0
1.27
19
203
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
28
2.51
1.45
1.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
38
264
1.46
1.39
1.3
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
67
515
1.33
1.37
1.7
2.0
nmol/l
408.4
390.2
0.30
48
456
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
40
284
1.43
1.32
5.2
4.7
mmol/l
25.9
24.9
1.19
34
259
(3014051) Protein [Presence] in Urine by Test strip
7
150
0.46
1.32
3.0
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
132
0.45
1.29
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
171
1.54
1.24
2.4
4.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
289
0.61
1.24
2.2
2.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
92
750
1.26
1.23
2.7
3.6
mmol/l
2.8
1.9
1.79
76
585
(3021589) Normoblasts [#/volume] in Blood
221
2469
0.85
1.21
12.3
10.7
e9/l
0.0
0.0
1.13
174
2006
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
600
1.28
1.17
2.9
3.8
mmol/l
1.2
1.2
0.40
62
508
(36660697) Celiac disease serology panel - Serum
20
308
0.64
1.17
1.5
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
47
352
1.36
1.17
1.9
1.8
ug/l
1.8
2.3
0.18
30
296
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
2.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
35
0.00
1.15
0.0
2.4
—
670.1
—
0
15
(3047189) Immunofixation for 24 hour Urine
0
36
0.00
1.14
0.0
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
53
681
0.76
1.12
2.3
6.6
mmol/l
10.4
12.1
1.03
44
640
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
231
2558
0.86
1.11
3.3
3.4
ng/l
1771.2
2144.6
0.60
190
2234
(3002256) Pathology report gross observation
61
768
0.78
1.11
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
164
0.54
1.09
1.2
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
8
41
1.96
1.09
1.5
1.1
—
—
—
0
0
(4024509)
11
59
1.88
1.07
1.5
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
736
1.24
1.07
2.4
2.7
ug/l
5.7
5.9
0.05
39
628
(3017181) Myelocytes/100 leukocytes in Blood
38
508
0.74
1.06
2.0
3.8
%
0.8
0.9
—
8
177
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
288
0.65
1.05
1.1
1.3
—
—
—
0
0
(4027681)
5
22
2.28
1.03
1.6
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
35
2.01
1.00
2.1
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
307
3312
0.88
0.99
6.2
8.2
e9/l
4.8
4.4
1.22
255
2873
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
9
159
0.56
0.99
2.7
2.3
g/l
3.6
3.7
—
9
147
(44813793)
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
274
2974
0.88
0.97
4.1
5.8
ug/l
2.7
5.0
0.87
213
2594
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
228
2069
1.14
0.95
2.5
4.0
ph
7.4
7.4
1.55
49
394
(3019225) pH of Specimen
81
674
1.23
0.94
4.8
4.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
49
384
1.29
0.93
4.7
3.9
%
45.7
47.1
0.15
49
379
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
256
2349
1.13
0.90
2.1
2.2
nmol/l
71.4
79.2
4.54
192
2002
(3007164) IgA [Mass/volume] in Serum or Plasma
70
842
0.81
0.88
1.2
1.5
g/l
2.2
2.9
1.85
31
476
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
754
0.81
0.87
3.5
4.8
%
38.3
33.0
1.45
27
469
(3028626) Oxygen [Partial pressure] in Capillary blood
11
180
0.61
0.87
2.2
3.1
kpa
8.1
7.6
0.52
11
159
(3002179) Metamyelocytes/100 leukocytes in Blood
34
441
0.76
0.81
2.1
3.7
%
2.7
0.6
—
7
126
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
281
0.70
0.79
1.3
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
14
211
0.66
0.79
2.0
3.4
mmol/l
24.8
24.9
0.03
14
175
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
24.4
—
0
19
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
24
0.00
0.79
0.0
1.8
—
64492.2
—
0
17
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
83
969
0.84
0.78
2.2
5.3
mmol/l
0.9
1.0
3.45
73
885
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
100
0.50
0.77
1.0
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
37
470
0.78
0.77
2.1
3.9
%
0.1
0.1
—
7
158
(40768443) Skin Pathology biopsy report
19
267
0.70
0.76
1.3
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
262
2816
0.90
0.76
4.4
5.0
e9/l
0.0
0.0
2.65
214
2397
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
161
0.62
0.76
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
52
633
0.81
0.76
3.1
8.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
474
4540
1.11
0.75
25.8
21.6
%
36.0
37.4
1.36
229
2586
(3045414) Leukocytes [Presence] in Urine
17
243
0.69
0.75
2.1
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
261
2804
0.90
0.75
4.4
5.0
e9/l
0.6
0.6
1.77
213
2372
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
153
1697
0.88
0.75
1.9
2.9
u/l
43.9
36.7
0.28
135
1614
(40758558) Short blood count panel - Blood
130
1458
0.87
0.74
5.8
6.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
154
1384
1.14
0.74
4.7
4.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
136
0.58
0.73
3.0
2.3
%
92.3
84.6
—
8
127
(3007853) Bacteria identified in Skin by Aerobe culture
90
778
1.18
0.73
1.6
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
25
2.01
0.72
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
25
2.01
0.72
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
171
0.64
0.72
1.2
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
92
1.53
0.72
3.3
2.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
404
4231
0.91
0.69
3.5
4.1
mm/h
13.3
16.1
3.17
345
3803
(3002385) Erythrocyte distribution width [Ratio]
406
4250
0.91
0.69
27.1
23.8
%
13.8
14.1
5.68
387
4135
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
29
222
1.32
0.69
2.7
2.5
pmol/l
4.3
4.2
0.25
21
191
(3015377) Calcium [Moles/volume] in Serum or Plasma
247
2296
1.11
0.68
2.2
3.4
mmol/l
2.3
2.3
1.35
192
1956
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
117
0.59
0.68
1.1
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
112
993
1.15
0.67
1.6
2.5
%
1.6
1.8
1.15
84
875
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
201
0.69
0.65
1.1
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
568
5839
0.90
0.65
33.2
28.4
e9/l
7.0
7.1
0.21
534
5610
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
436
0.79
0.64
1.5
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
568
5837
0.90
0.63
33.4
28.6
g/l
126.1
130.7
12.15
540
5691
(3035941) MCH [Entitic mass]
568
5836
0.90
0.63
33.0
28.3
pg
30.6
30.5
0.51
540
5692
(3026361) Erythrocytes [#/volume] in Blood
568
5836
0.90
0.63
33.1
28.4
e12/l
4.2
4.3
10.67
535
5608
(3024731) MCV [Entitic volume]
568
5835
0.90
0.62
33.0
28.3
fl
92.3
92.1
0.78
540
5693
(3007461) Platelets [#/volume] in Blood
568
5835
0.90
0.62
33.1
28.4
e9/l
232.2
232.0
0.01
534
5639
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
54
454
1.20
0.61
4.2
4.2
mmol/l
2.4
2.0
0.40
38
339
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
22
0.00
0.59
0.0
1.2
—
15.5
—
0
14
(3033799) Differential panel - Peritoneal fluid
0
22
0.00
0.59
0.0
2.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
22
0.00
0.59
0.0
1.5
—
22.8
—
0
22
(3012095) Magnesium [Moles/volume] in Serum or Plasma
122
1099
1.13
0.59
1.7
3.0
mmol/l
0.8
0.8
0.42
103
1015
(3037556) Urate [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
0.9
—
0
23
(3008536) Aspergillus sp Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
43
356
1.22
0.57
1.6
4.0
mmol/l
25.7
23.8
2.75
38
326
(3019060) Gas panel - Arterial blood
67
579
1.17
0.57
4.4
4.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
270
2860
0.91
0.56
4.8
5.1
e9/l
1.5
1.8
3.85
226
2477
(3026389) Candida sp identified in Specimen by Organism specific culture
11
73
1.51
0.56
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
88
0.57
0.56
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
89
0.56
0.56
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
47
557
0.83
0.56
2.4
4.0
ng/l
69.6
101.1
2.13
34
469
(3025159) Blasts/100 leukocytes in Blood
37
448
0.82
0.55
2.1
3.9
%
0.0
0.1
—
7
136
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
124
0.64
0.55
1.4
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
73
640
1.16
0.53
1.6
2.0
g/l
0.2
0.2
0.23
65
582
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
143
1.34
0.53
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
70
613
1.16
0.52
3.6
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
276
2910
0.92
0.51
4.9
5.1
e9/l
0.2
0.2
6.02
225
2510
(3049717) Cytology report of Urine Cyto stain
30
368
0.81
0.51
2.2
3.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
78
876
0.88
0.49
1.7
4.0
u/l
228.3
250.0
1.15
65
819
(3023103) Potassium [Moles/volume] in Serum or Plasma
566
5791
0.92
0.49
28.4
23.9
mmol/l
4.0
4.0
6.73
540
5605
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
563
5496
1.09
0.48
25.1
19.4
mg/l
32.9
29.2
1.51
515
4605
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
288
0.79
0.47
2.4
2.5
—
13.4
—
0
5
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
65
571
1.15
0.47
1.8
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
48
1.46
0.47
2.3
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
142
0.70
0.46
1.4
2.0
mg/l
8.3
13.4
—
10
128
(3012441) Differential panel - Pleural fluid
8
117
0.68
0.46
1.1
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
117
0.68
0.46
2.0
2.3
%
56.0
63.3
—
8
117
(3048689) Calprotectin [Mass/mass] in Stool
39
458
0.84
0.44
2.1
1.9
ug/g
251.9
167.1
0.61
27
358
(3019550) Sodium [Moles/volume] in Serum or Plasma
566
5782
0.92
0.44
28.4
23.7
mmol/l
139.8
139.5
2.34
541
5603
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
393
0.83
0.44
7.7
9.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
150
0.73
0.41
1.6
3.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.9
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.3
—
27.3
—
0
10
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
34
1.47
0.40
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
104
0.67
0.39
1.1
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
105
0.66
0.39
1.4
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
19
0.00
0.39
0.0
1.3
—
108.2
—
0
13
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.8
—
839.6
—
0
5
(3009343) pH of Capillary blood
54
477
1.14
0.38
4.4
4.2
ph
7.4
7.4
—
9
55
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
112
0.71
0.37
1.4
1.1
—
19.1
—
0
7
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
113
0.70
0.37
1.3
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
24
198
1.22
0.36
1.8
3.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
254
2654
0.94
0.36
5.1
5.6
%
8.6
9.1
1.85
218
2449
(3006504) Eosinophils/100 leukocytes in Blood
253
2643
0.94
0.36
4.7
5.3
%
2.3
2.8
4.33
217
2435
(40767503) Oxygen content in Capillary blood by calculation
20
162
1.24
0.36
2.4
2.6
%
16.8
15.3
—
9
77
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
79
0.63
0.35
1.4
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
124
0.72
0.35
1.3
1.5
—
—
—
0
0
(4034850)
23
190
1.22
0.35
13.4
14.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
409
3976
1.06
0.34
3.6
3.6
pmol/l
15.4
15.2
0.59
335
3446
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
210
0.81
0.33
1.8
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
99
1069
0.92
0.33
3.7
4.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
54
483
1.13
0.33
4.4
4.2
kpa
5.2
5.2
0.18
47
440
(3017569) Oxygen content in Arterial blood
6
46
1.31
0.33
1.0
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
542
5521
0.94
0.33
24.6
19.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
154
1453
1.07
0.32
2.7
3.3
mmol/l
2.5
2.5
0.17
121
1262
(3003694) ABO and Rh group [Type] in Blood
121
1291
0.93
0.31
1.2
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
250
2401
1.06
0.31
2.6
2.8
ug/l
164.1
164.5
0.01
193
2131
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
197
0.81
0.31
1.1
1.1
iu/ml
97.4
121.1
—
5
63
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
96
0.73
0.31
1.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
96
0.73
0.31
1.1
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
100
0.70
0.30
3.0
2.9
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
56
1.25
0.29
1.6
1.4
—
57.1
—
0
7
(3044640) Blood type and Crossmatch panel - Blood
217
2080
1.06
0.29
2.1
2.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
249
2585
0.95
0.29
5.0
5.3
%
0.5
0.6
1.71
214
2383
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
176
1.20
0.29
1.5
1.4
ug/g
264.2
264.5
0.00
13
104
(3018010) Neutrophils/100 leukocytes in Blood
254
2635
0.95
0.29
5.4
5.3
%
63.8
59.8
5.79
219
2429
(3042936) Bacteria identified in Isolate by Culture
92
988
0.92
0.28
1.6
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
147
1550
0.94
0.28
2.1
2.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
151
0.79
0.28
1.2
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
32
280
1.15
0.28
1.7
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
116
0.77
0.27
2.7
3.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
292
3014
0.95
0.27
3.2
3.2
u/l
57.1
60.1
0.10
257
2706
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
271
2802
0.95
0.27
3.6
4.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
261
2700
0.95
0.26
5.5
5.6
%
21.2
24.6
5.84
223
2471
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
99
927
1.08
0.26
4.4
6.6
kpa
5.1
5.0
0.28
92
882
(3023520) Reticulocytes [#/volume] in Blood
79
733
1.09
0.26
1.7
2.6
e9/l
59.3
68.3
2.27
61
578
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
171
0.82
0.26
1.4
2.4
ug/min
48.9
89.4
—
5
101
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
1.0
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
36
404
0.89
0.26
1.4
2.0
g/l
1.5
1.5
0.17
25
351
(3027801) Oxygen [Partial pressure] in Arterial blood
99
928
1.08
0.26
4.5
6.6
kpa
11.4
11.4
0.01
91
884
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
73
1.24
0.25
2.7
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
46
416
1.11
0.25
3.5
3.1
e6/l
0.5
0.4
0.09
46
408
(3037756) Immunofixation for Serum or Plasma
15
180
0.83
0.24
1.1
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
161
1.18
0.24
1.1
2.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
97
1.24
0.23
1.7
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
381
1.11
0.22
2.6
2.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.1
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
556
1.09
0.21
1.6
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4212803)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
173.2
—
0
5
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1385.5
—
0
10
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
12
0.00
0.21
0.0
11.8
—
6.6
—
0
12
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
103
0.77
0.21
1.3
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
49.8
—
0
13
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
9.6
—
0
13
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
1.6
—
0
6
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
14
0.00
0.20
0.0
2.0
—
1.2
—
0
14
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
1.9
—
0
14
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
98
929
1.06
0.20
4.5
6.7
mmol/l
1.8
1.2
1.18
79
707
(3022621) pH of Urine by Test strip
48
442
1.09
0.20
5.4
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
114
0.79
0.20
1.1
1.4
—
—
—
0
0
(3013512) EKG study
196
2026
0.96
0.20
5.1
4.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
50
1.20
0.19
1.2
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
19
218
0.87
0.19
1.4
2.7
g/l
0.0
0.0
0.00
12
197
(3044242) Glucose [Moles/volume] in Arterial blood
6
51
1.18
0.19
1.0
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
165
1.16
0.19
8.2
4.1
mg/l
23.8
30.2
0.44
13
111
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
52
1.16
0.19
1.3
1.2
nmol/l
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
82
1.22
0.17
1.5
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
68
0.73
0.17
1.0
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
76
0.79
0.15
1.3
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
77
0.78
0.15
1.2
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
296
0.91
0.15
1.3
2.6
g/l
3.3
3.2
0.06
13
225
(3044941) Cell count panel - Synovial fluid
11
93
1.19
0.14
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
89
0.78
0.14
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
7
90
0.78
0.14
1.0
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
316
0.91
0.14
1.3
2.5
g/l
6.8
7.5
0.72
14
229
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
316
0.91
0.14
1.3
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
97
0.82
0.13
1.0
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
315
0.92
0.13
1.3
2.5
g/l
4.2
3.7
0.26
14
221
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
221
0.90
0.13
1.4
2.7
g/l
0.0
0.0
0.00
12
197
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
74
773
0.95
0.12
2.3
2.9
ng/l
238.5
263.3
0.17
66
706
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
85
1.18
0.12
2.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
126
1222
1.04
0.12
1.7
1.7
mg/l
1.8
1.5
0.22
98
975
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
189
0.90
0.12
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
405
1.07
0.12
8.1
4.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
292
0.92
0.12
1.3
2.6
g/l
8.3
10.6
2.90
15
241
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
302
0.92
0.11
1.7
2.5
u/ml
0.5
0.3
0.64
13
173
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
153
1.11
0.11
1.5
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
115
1184
0.97
0.10
1.8
2.5
umol/l
11.1
11.9
0.66
93
1078
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
698
0.96
0.10
1.6
2.8
umol/l
11.6
10.5
0.12
53
607
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
1405
1.03
0.10
4.1
4.1
ng/l
72.0
285.7
3.49
129
1255
(3000012) Reticulocyte production index
5
46
1.09
0.09
1.0
1.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
25
268
0.93
0.09
1.6
2.7
g/l
1.6
1.4
0.08
16
223
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
57
1.05
0.08
2.2
1.7
mu/l
264.8
327.2
—
6
52
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.3
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
58
1.03
0.08
1.5
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
60
0.83
0.08
1.0
1.2
—
55.2
—
0
10
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
60
0.83
0.08
1.4
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
70
0.86
0.07
1.3
1.4
u/l
11.8
14.3
—
6
64
(3051611) Lipemic interference index of Serum or Plasma
6
73
0.82
0.07
1.3
3.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
174
0.92
0.07
1.3
1.4
—
—
—
0
0
(4146454)
8
74
1.08
0.07
2.5
2.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
108
1.11
0.07
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
101
1034
0.97
0.07
2.0
2.6
%
21.3
21.7
0.12
71
874
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
83
0.84
0.07
1.3
1.2
u/l
10.0
13.7
—
7
76
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
83
0.84
0.07
1.9
4.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
85
0.82
0.07
1.9
5.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
35
334
1.05
0.07
3.3
3.4
e9/l
4.0
4.1
0.07
15
227
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
346
0.95
0.06
1.7
1.5
%
1.5
1.8
1.41
26
258
(3004789) Transferrin [Mass/volume] in Serum or Plasma
107
1093
0.98
0.06
1.8
2.5
g/l
2.1
2.2
2.04
80
994
(3022313) Gas panel - Capillary blood
37
354
1.05
0.06
5.1
4.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
102
0.88
0.06
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
149
1.08
0.05
1.3
1.6
e6/l
18458.6
19138.0
—
10
102
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
22
232
0.95
0.05
1.4
2.7
g/l
0.0
0.0
0.67
14
207
(3020891) Body temperature
33
318
1.04
0.04
3.8
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
119
0.92
0.04
1.5
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
200
1.05
0.03
1.1
3.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
488
4898
0.99
0.03
4.7
4.6
mu/l
2.0
2.1
1.10
405
4277
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
26
270
0.96
0.03
1.2
3.5
—
2.2
—
0
20
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
195
1934
1.01
0.03
2.3
2.5
u/l
53.4
56.9
0.39
177
1774
(42529406) Shigella sp [Presence] in Stool by Culture
16
169
0.95
0.03
1.1
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
331
3295
1.01
0.02
3.6
6.1
umol/l
12.3
12.8
0.35
296
3104
(3032080) INR in Blood by Coagulation assay
309
3077
1.01
0.02
12.5
12.5
inr
1.4
1.4
0.37
85
846
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
92
911
1.01
0.01
1.2
1.2
u/ml
0.6
1.4
1.90
20
211
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
167
0.96
0.01
1.1
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
66
668
0.99
0.01
1.5
2.8
g/l
64.8
65.8
0.35
47
591
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
277
0.97
0.01
1.3
3.5
mg/l
26.1
53.8
1.59
19
225
(42870588) Differential panel, method unspecified - Blood
199
1999
0.99
0.01
4.8
5.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
415
4158
1.00
0.01
28.0
26.4
g/l
330.2
330.7
0.48
394
4111
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
166
0.96
0.00
1.1
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
27
276
0.98
0.00
1.3
3.5
mg/l
50.8
85.8
0.77
20
221
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
107
1.03
0.00
1.6
2.7
e9/l
5.0
4.7
0.08
11
107
(3033658) Prothrombin time (PT) actual/Normal
157
1565
1.00
0.00
3.3
4.1
%
78.9
80.3
0.31
150
1530
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
25
248
1.01
0.00
1.4
2.6
g/l
35.3
36.4
0.28
13
205
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
111
0.99
0.00
1.7
3.1
%
56.2
61.8
0.64
11
111
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
460
4604
1.00
0.00
4.9
7.6
u/l
83.6
82.2
0.19
402
4276
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
572
1.00
0.00
2.1
2.3
u/l
44.7
33.1
0.40
42
485
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
4.5
—
13.7
—
0
6
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
52
0.96
0.00
1.6
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
8.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
78
0.90
0.00
1.9
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
18.1
—
0
9
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
6
69
0.87
0.00
1.0
1.5
—
66.8
—
0
48
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
93
0.97
0.00
1.9
1.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
80.4
—
0
5
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
54
0.93
0.00
1.2
1.6
%
8.1
11.3
—
5
54
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
73
0.96
0.00
1.1
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
2.0
—
2.3
—
0
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
6
62
0.97
0.00
1.0
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PD_DEMENTIA – Dementia due to Parkinson's disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).